Multiple gene expression regulators

The term 'Multiple gene expression regulators' refers to a broad and heterogeneous group of proteins and molecular complexes that control the process of gene expression at various levels, including transcription, RNA processing, and translation. This category encompasses transcription factors, which bind to specific DNA sequences to promote or inhibit RNA polymerase activity (PubMed: 29074342), and epigenetic modifiers like histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) that alter chromatin accessibility (UniProt: Q13547). Because this term describes a functional class rather than a single molecular entity, it is not considered a specific therapeutic target in pharmacological databases. Instead, individual members within this group are targeted to treat diseases like cancer, where dysregulated gene expression drives pathogenesis (NIH: StatPearls - HDAC Inhibitors). Drugs interacting with these regulators, such as Vorinostat or Azacitidine, often aim to restore normal gene expression patterns or induce apoptosis in malignant cells. However, the broad impact of these regulators on cellular homeostasis often leads to significant safety concerns and off-target effects, including hematological toxicity and gastrointestinal distress. Consequently, while these regulators are vital for cellular function, the term itself is too broad for precise drug-target annotation.

Other names

Gene expression modulatorsTranscriptional and epigenetic regulatorsChromatin modifiersTranscriptional regulators

Modulation of gene expression through epigenetic modification (e.g., histone deacetylation, DNA methylation) or direct control of the transcriptional machinery.